Stockscreener 앱 받기
28.85
3.81%
1.06
전일 마감가:
$27.79
열려 있는:
$26.97
하루 거래량:
283.14K
Relative Volume:
0.75
시가총액:
$477.12M
수익:
$3.25M
순이익/손실:
$-116.80M
주가수익비율:
-9.459
EPS:
-3.05
순현금흐름:
$-98.17M
1주 성능:
-0.03%
1개월 성능:
+15.40%
6개월 성능:
+380.71%
1년 성능:
+181.74%
1일 변동 폭
$26.78
$29.27
1주일 범위
$26.78
$30.12
52주 변동 폭
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
명칭
Rapt Therapeutics Inc
전화
(650) 489-9000
주소
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
RAPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
28.85 | 770.09M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 개시 | Guggenheim | Buy |
| 2025-10-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-09-26 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2025-05-22 | 재개 | H.C. Wainwright | Buy |
| 2024-12-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-11-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-21 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | 개시 | Evercore ISI | Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-09-14 | 개시 | Berenberg | Buy |
| 2023-08-09 | 개시 | Stifel | Buy |
| 2023-06-15 | 개시 | Barclays | Overweight |
| 2023-01-04 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2022-09-21 | 개시 | CapitalOne | Overweight |
| 2022-05-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-09 | 개시 | JP Morgan | Overweight |
| 2021-08-12 | 개시 | SVB Leerink | Outperform |
| 2021-06-21 | 개시 | Piper Sandler | Overweight |
| 2020-06-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-04-13 | 개시 | ROTH Capital | Buy |
| 2019-11-25 | 개시 | BMO Capital Markets | Outperform |
| 2019-11-25 | 개시 | UBS | Buy |
| 2019-11-25 | 개시 | Wells Fargo | Outperform |
모두보기
Rapt Therapeutics Inc 주식(RAPT)의 최신 뉴스
What to expect from RAPT Therapeutics Inc. in the next 30 daysJuly 2025 Retail & Safe Swing Trade Setups - newser.com
Why RAPT Therapeutics Inc. stock appeals to dividend seekersPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
How RAPT Therapeutics Inc. (0RA0) stock stacks up against competitorsProfit Target & Fast Exit/Entry Strategy Plans - newser.com
Is RAPT Therapeutics Inc. stock reversal real or fakeJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Leading vs lagging indicators on RAPT Therapeutics Inc. performanceEntry Point & Real-Time Market Trend Scan - newser.com
RAPT Therapeutics Inc. recovery potential after sell offJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
How RAPT Therapeutics Inc. stock benefits from tech adoptionWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Can RAPT Therapeutics Inc. recover in the next quarterMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com
Why RAPT Therapeutics Inc. (0RA) stock is trending on social mediaQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Why retail investors favor RAPT Therapeutics Inc. stock2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Can RAPT Therapeutics Inc. (0RA) stock attract ESG investments2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Can RAPT Therapeutics Inc. (0RA) stock resist broad market declinesEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
What to do if you’re stuck in RAPT Therapeutics Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Technical signs of recovery in RAPT Therapeutics Inc.Fed Meeting & Daily Chart Pattern Signal Reports - newser.com
How institutional buying supports RAPT Therapeutics Inc. stock2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com
What macro factors could drive RAPT Therapeutics Inc. (0RA0) stock higherJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Can RAPT Therapeutics Inc. stock outperform in 2025 bull marketMarket Movers & Accurate Buy Signal Notifications - newser.com
RAPT Therapeutics: Strong Promise In Immunology, Looks Like An Opportunity At These Prices - Seeking Alpha
Can RAPT Therapeutics Inc. (0RA) stock survive global slowdownJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
Can RAPT Therapeutics Inc. (0RA) stock ride next bull market cycle2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Will RAPT Therapeutics Inc. (0RA) stock beat revenue estimatesJuly 2025 Fed Impact & Verified Entry Point Signals - Fundação Cultural do Pará
Will RAPT Therapeutics Inc. (0RA0) stock outperform value peers2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Can RAPT Therapeutics Inc. (0RA0) stock sustain margin levelsChart Signals & High Win Rate Trade Tips - newser.com
Is RAPT Therapeutics Inc. (0RA0) stock a buy before earnings resultsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Rapt Therapeutics Inc (RAPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.07%
자본화:
|
볼륨(24시간):